MCID: GST044
MIFTS: 61

Gastritis

Categories: Gastrointestinal diseases, Infectious diseases

Aliases & Classifications for Gastritis

MalaCards integrated aliases for Gastritis:

Name: Gastritis 12 28 51 41 14 69 59
Acute Gastric Mucosal Erosion 12 69
Erosive Gastropathy 12 69
Erosive Gastritis 12 69
Idiopathic Erosive/hemorrhagic Gastritis 69
Gastritis Erosive 51

Classifications:



Summaries for Gastritis

PubMed Health : 59
About gastritis: The membranes lining the stomach wall protect it from acid and germs. If this protective lining is irritated or damaged, it can become inflamed. Long-lasting inflammations can further damage the stomach lining and lead to stomach (gastric) ulcers.Inflammation of the stomach lining is called gastritis. It is usually caused by certain bacteria or anti-inflammatory medication.There are two kinds of gastritis: acute and chronic. Acute gastritis is typically accompanied by very noticeable stomach and bowel problems that usually go away again on their own after a few days. Chronic gastritis, on the other hand, sometimes goes unnoticed. People may only realize they have it when complications like stomach ulcers arise.

MalaCards based summary : Gastritis, also known as acute gastric mucosal erosion, is related to autoimmune atrophic gastritis and atrophic gastritis, and has symptoms including dyspepsia and gastric irritation. An important gene associated with Gastritis is PGC (Progastricsin), and among its related pathways/superpathways are Toll-Like receptor Signaling Pathways and Defensins. The drugs Amoxicillin and Clarithromycin have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and liver, and related phenotype is digestive/alimentary.

Disease Ontology : 12 A stomach disease that is an inflammation of the lining of the stomach.

Wikipedia : 72 Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a... more...

Related Diseases for Gastritis

Diseases in the Gastritis family:

Viral Gastritis Bacterial Gastritis

Diseases related to Gastritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 272)
# Related Disease Score Top Affiliating Genes
1 autoimmune atrophic gastritis 34.2 CHGA GAST
2 atrophic gastritis 32.3 ADH7 CHGA CXCL8 GAST GHRL IL1B
3 helicobacter pylori infection 31.8 CXCL1 CXCL8 GAST IL1B IL1RN S100A8
4 dyspepsia 31.7 CXCL8 GHRL HRH2 PGC PTGS2
5 esophagitis 30.5 CXCL8 HRH2 IL1B PTGS2
6 gastric cancer 30.4 AREG GAST IL1RN PTGS2 S100A8 TFF2
7 gastric adenocarcinoma 30.2 CHGA GAST IL1RN PTGS2 S100A8
8 zollinger-ellison syndrome 30.2 CHGA GAST HRH2
9 duodenal ulcer 30.2 CXCL8 GAST HRH2 IL1B IL1RN S100A8
10 gastric ulcer 30.2 CXCL8 GAST HRH2 IL1B IL1RN PTGS2
11 gastric neuroendocrine neoplasm 30.0 CHGA GAST
12 arthritis 30.0 CXCL8 IL1B IL1RN PTGS2
13 stomach disease 30.0 AREG CXCL8 GAST GHRL HRH2 IL1B
14 crohn's colitis 29.9 CXCL8 IL1B NOS2
15 gastroesophageal reflux 29.7 CXCL8 GHRL HRH2 IL1B PTGS2
16 active peptic ulcer disease 29.5 HRH2 PTGS2
17 peptic ulcer disease 29.5 CXCL8 GAST GHRL HRH2 IL1B IL1RN
18 intestinal disease 29.3 AREG CXCL8 GHRL IL1B
19 rheumatoid arthritis 29.2 CXCL1 CXCL8 IL1B IL1RN PTGS2
20 gastrointestinal system disease 28.8 AREG CXCL8 GAST GHRL IL1B PTGS2
21 inflammatory bowel disease 27.2 AREG CHGA CXCL1 CXCL8 DEFA5 DEFB1
22 gastritis, familial giant hypertrophic 12.2
23 collagenous gastritis 12.2
24 bacterial gastritis 12.2
25 herpetic gastritis 12.2
26 alcoholic gastritis 12.2
27 granulomatous gastritis 12.2
28 chronic erosive gastritis 12.1
29 lymphocytic gastritis 12.1
30 eosinophilic gastritis 12.0
31 necrotizing gastritis 12.0
32 viral gastritis 12.0
33 pediatric collagenous gastritis 12.0
34 cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation 11.9
35 fungal gastritis 11.8
36 eosinophilic enteropathy 11.5
37 lubani-al saleh-teebi syndrome 11.1
38 immunodeficiency 12 10.9
39 duodenitis 10.9
40 recurrent corneal erosion 10.6 CXCL8 IL1B
41 bagassosis 10.5 CXCL8 IL1B
42 gastrointestinal neuroendocrine benign tumor 10.5 CHGA GAST
43 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.5
44 gastroduodenitis 10.5
45 acute generalized exanthematous pustulosis 10.4 CXCL8 PTGS2
46 aseptic meningitis 10.4 CXCL8 IL1B IL1RN
47 pylorospasm 10.4 GAST GHRL
48 endometrial disease 10.4 CXCL8 IL1B PTGS2
49 silicosis 10.4 CXCL8 IL1B IL1RN
50 pharyngitis 10.4 CXCL8 IL1B PTGS2

Graphical network of the top 20 diseases related to Gastritis:



Diseases related to Gastritis

Symptoms & Phenotypes for Gastritis

UMLS symptoms related to Gastritis:


dyspepsia, gastric irritation

MGI Mouse Phenotypes related to Gastritis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.17 AREG GAST GHRL HRH2 NOS2 PTGS2

Drugs & Therapeutics for Gastritis

PubMedHealth treatment related to Gastritis: 59

If you notice that stress, alcohol or nicotine affect your symptoms, you can try to change your diet, stop drinking alcohol, quit smoking and reduce stress in everyday life. If these lifestyle changes are not enough to relieve the symptoms, medication is considered.Gastritis not caused by Helicobacter pylori is usually treated with medication to lower acid levels. Depending on the type and severity of the symptoms, the following drugs can be used:Proton pump inhibitors (PPIs) like omeprazole or pantoprazole reduce the production of stomach acid.H2 blockers such as ranitidine and famotidine also reduce acid production.Antacids like aluminium hydroxide or magnesium hydroxide neutralize the acid already in your stomach.If the gastritis is caused by a Helicobacter infection and is accompanied by noticeable symptoms, it will be treated using a combination of two or three antibiotics and an acid-lowering proton pump inhibitor.If the gastritis is caused by an NSAID painkiller, it is a good idea to consult your doctor about switching to a different painkiller or combining it with an acid-lowering medication. Should an NSAID have to be taken regularly, it is possible to take it along with acid-lowering medication from the start, as a precaution.

Drugs for Gastritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 284)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
2
Clarithromycin Approved Phase 4,Phase 2,Phase 3,Phase 1 81103-11-9 84029
3
Metronidazole Approved Phase 4,Phase 2,Phase 3 443-48-1 4173
4
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 117976-89-3 5029
5
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 73590-58-6 4594
6
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2 161796-78-7, 119141-88-7 9579578 4594
7
Histamine Approved, Investigational Phase 4,Phase 1 51-45-6, 75614-87-8 774
8
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
9
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
10
Hydroxocobalamin Approved Phase 4 13422-51-0 5460373 44475014 11953898
11
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
12
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
13
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
14
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
15
Moxifloxacin Approved, Investigational Phase 4,Phase 3 151096-09-2, 354812-41-2 152946
16
Norgestimate Approved, Investigational Phase 4,Phase 3 35189-28-7 6540478
17
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
18
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 1 100986-85-4 149096
19
Ofloxacin Approved Phase 4,Phase 3,Phase 1 82419-36-1 4583
20
Furazolidone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 67-45-8 5323714 3435
21
Ethanol Approved Phase 4,Phase 2 64-17-5 702
22
Sucralfate Approved Phase 4 54182-58-0 0
23
Amphotericin B Approved, Investigational Phase 4 1397-89-3 5280965 14956
24 Titanium dioxide Approved Phase 4 13463-67-7
25
Potassium Citrate Approved, Investigational, Vet_approved Phase 4
26
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 564-25-0 54671203
27
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
28
Verapamil Approved Phase 4 52-53-9 2520
29
Pectin Approved, Vet_approved Phase 4 9000-69-5 441476
30
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
31
Ranitidine Approved Phase 4 66357-59-3, 66357-35-5 3001055
32
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
33
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
34
Methylcobalamin Approved, Experimental, Investigational, Nutraceutical Phase 4 13422-55-4
35
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1 77-92-9 311
36
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
37 Licorice Approved, Nutraceutical Phase 4
38
Coenzyme Q10 Approved, Investigational, Nutraceutical Phase 4 303-98-0 5281915
39 Rebamipide Investigational Phase 4,Phase 3 90098-04-7
40 Mosapride Investigational Phase 4,Phase 1 112885-41-3
41 Antacids Phase 4,Phase 3,Phase 2,Phase 1
42 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
43 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
44 Antiparasitic Agents Phase 4,Phase 2,Phase 3
45 Antiprotozoal Agents Phase 4,Phase 2,Phase 3
46 Anti-Ulcer Agents Phase 4,Phase 3,Phase 2,Phase 1
47 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 2,Phase 3
48 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
49 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Proton pump inhibitors Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 222)

# Name Status NCT ID Phase Drugs
1 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
2 Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice Unknown status NCT01273441 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
3 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication Unknown status NCT01464060 Phase 4 PPI, amoxicillin, metronidazole and clarithromycin;PPI, amoxicillin, metronidazole and clarithromycin
4 Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia Unknown status NCT02134405 Phase 4 Rebamipide;Placebo (for Esomeprazole);Esomeprazole
5 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
6 Clinical Effect of Rebamipide on Chronic Gastritis Completed NCT02393430 Phase 4 Rebamipide
7 Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients Completed NCT02356679 Phase 4 Eupasidin-s Tab;Stillen Tab.
8 A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis Completed NCT01284647 Phase 4 Teprenone capsule and placebo of sucralfate;Sucralfate and placebo of teprenone
9 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4 Stillen Tab.;Mucosta Tab.
10 Is a Reporting System for Gastritis or Duodenitis (Modified Lanza Scale) Reproducible? Completed NCT00852150 Phase 4
11 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
12 Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Completed NCT01119768 Phase 4 Esomeprazole;Esomeprazole
13 Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer Completed NCT01190657 Phase 4 Selbex;Selbex
14 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment Completed NCT00534443 Phase 4
15 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy Completed NCT02633930 Phase 4 Berberine;clarithromycin;Bismuth;Lansoprazole;amoxicillin
16 Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Completed NCT02296021 Phase 4 Berberine;Bismuth;esomeprazole;amoxicillin;clarithromycin
17 High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication Completed NCT01888237 Phase 4 Double dose of PPI;sequence of drug use
18 Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori Completed NCT01969331 Phase 4
19 Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection Completed NCT02835560 Phase 4 Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy;Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy
20 A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection Completed NCT01219764 Phase 4 Rabeprazole, metronidazole, Clarithromycin, Amoxicillin
21 Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy Completed NCT01792700 Phase 4 esomeprazole;tripotassium dicitrate bismuthate;metronidazole;tetracycline;moxifloxacin;amoxicillin
22 Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori Completed NCT02352701 Phase 4 Noltec tab. 10mg;Chongkundang Amoxicillin Cap. 500mg;Cravit Tab. 500mg
23 The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia Completed NCT02037776 Phase 4 Rikkunshito;Rikkunshito placebo
24 Efficacy of Banhasasim-tang on Functional Dyspepsia Completed NCT00987805 Phase 4
25 Lansoprazole Versus Mosapride for Functional Dyspepsia Completed NCT00663897 Phase 4 lansoprazole;mosapride
26 Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Recruiting NCT02175186 Phase 4 ALBIS;Placebo
27 Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Recruiting NCT02047994 Phase 4 Triple therapy
28 Difference of Gastric Microbiota in the Process of Correa's Model. Recruiting NCT02833363 Phase 4
29 Bismuth Based Quadruple Therapy 10 Days in Children Recruiting NCT03299725 Phase 4 colloidal bismuth sub-citrate
30 The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori Recruiting NCT03220542 Phase 4 Probiotics;Esomeprazole;Amoxicillin;Clarithromycin
31 Intraluminal Therapy for Helicobacter Pylori Infection Recruiting NCT03124420 Phase 4 Lansoprazole;Amoxicillin;Clarithromycin
32 Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation Recruiting NCT02067182 Phase 4 Dabigatran
33 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Active, not recruiting NCT02679508 Phase 4 Vonoprazan;Lansoprazole
34 The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study Not yet recruiting NCT02933229 Phase 4 H. pylori eradication
35 The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers Not yet recruiting NCT03342456 Phase 4 Doxycycline Hyclate Enteric-Coated Capsules;Amoxicillin Capsules;Ilaprazole Enteric-Coated Tablets;Furazolidone Tablets;Potassium Citrate Tablets
36 Intragastric pH and Bismuth Effect for H. Pylori Eradication Not yet recruiting NCT02894892 Phase 4 (A)Bismuth;(B)Bismuth;(C)Bismuth;(D)Esomeprazole and Bismuth;(E)Esomeprazole and Bismuth;(F)Esomeprazole and Bismuth
37 Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia Not yet recruiting NCT03004118 Phase 4 Placebo Oral Tablet;Ursochol oral tablet
38 Lansoprazole Preventing Gastroduodenal Stress Ulcerations Terminated NCT00220909 Phase 4 Lansoprazole
39 Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia Terminated NCT00590408 Phase 4
40 The Clinical Significance of Acid Rebound in Functional Dyspepsia Terminated NCT01373970 Phase 4 Placebo;Pantoprazole + Placebo
41 Lansoprazole for Subgroups of Functional Dyspepsia Terminated NCT01040455 Phase 4 Lansoprazole;placebo
42 Esomeprazole Treatment for Patients With Lymphocytic Gastritis Unknown status NCT00455754 Phase 3 Esomeprazole
43 A Study to Evaluate the Efficacy and Safety of DA-5204 Unknown status NCT02282670 Phase 3 DA-5204;Stillen tab.
44 A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Unknown status NCT01813812 Phase 3 DA-6034;Rebamipide 300mg
45 Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection Unknown status NCT00455806 Phase 3 esomeprazole;moxifloxacin;amoxicillin
46 A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer Unknown status NCT01065688 Phase 3
47 Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection Unknown status NCT00197418 Phase 2, Phase 3 rabeprazole, amoxicillin, clarithromycin, metronidazole
48 Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori Unknown status NCT00149084 Phase 3 Lansoprazole, clarithromycin, amoxicillin
49 Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1% Unknown status NCT02068859 Phase 3 Diclofenac Cream 8%;Diclofenac Gel 1%
50 Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition Unknown status NCT01052896 Phase 3 Gabapentin;Placebo

Search NIH Clinical Center for Gastritis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: gastritis

Genetic Tests for Gastritis

Genetic tests related to Gastritis:

# Genetic test Affiliating Genes
1 Gastritis 28

Anatomical Context for Gastritis

MalaCards organs/tissues related to Gastritis:

38
Testes, T Cells, Liver, Colon, Spleen, Thyroid, Pancreas

Publications for Gastritis

Articles related to Gastritis:

(show top 50) (show all 1817)
# Title Authors Year
1
Large-cell neuroendocrine carcinoma arising from a gastritis cystica polyposa. ( 29305822 )
2018
2
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer. ( 29434796 )
2018
3
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition. ( 29307809 )
2018
4
Helicobacter pylori infection increases sirt2 gene expression in gastric epithelial cells of gastritis patients. ( 29355701 )
2018
5
Emphysematous gastritis secondary to<i>Sarcina ventriculi</i>. ( 29437820 )
2018
6
Symptomatic Non-acidic Reflux in a Patient With Chronic Autoimmune Atrophic Gastritis Successfully Treated With Anti-reflux Surgery. ( 29291616 )
2018
7
Host response genes associated with nodular gastritis in H. pylori infection. ( 29415337 )
2018
8
Impact of SNP-SNP interactions of DNA repair gene<i>ERCC5</i>and metabolic gene<i>GSTP1</i>on gastric cancer/atrophic gastritis risk in a Chinese population. ( 29434449 )
2018
9
Decrease in<i>PSCA</i>expression caused by<i>Helicobacter pylori</i>infection may promote progression to severe gastritis. ( 29423095 )
2018
10
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic<i>Helicobacter pylori</i>Infection. ( 29378910 )
2018
11
Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect. ( 29353492 )
2018
12
Utility of a laboratory score in the prediction of altered autonomic nervous system function in autoimmune gastritis. ( 29391305 )
2018
13
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. ( 29306868 )
2018
14
Berberine demonstrates anti-inflammatory properties in Helicobacter pylori-infected mice with chronic gastritis by attenuating the Th17 response triggered by the B cell-activating factor. ( 29345340 )
2018
15
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. ( 29193217 )
2018
16
The key is in the air: transthoracic echocardiogram leading to diagnose emphysematous gastritis. ( 29401257 )
2018
17
NMR-based metabonomics and correlation analysis reveal potential biomarkers associated with chronic atrophic gastritis. ( 27697573 )
2017
18
Gastric neuroendocrine tumor with hypergastrinemia following type B chronic atrophic gastritis: a case report. ( 28163290 )
2017
19
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis-Authors' reply. ( 29105133 )
2017
20
CHINESE HERBAL DECOCTION AS A COMPLEMENTARY THERAPY FOR ATROPHIC GASTRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. ( 28638893 )
2017
21
Gastrointestinal: Aspergillus granulomatous gastritis. ( 28752685 )
2017
22
Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis. ( 27806647 )
2017
23
H. pylori infection increases gastric mucosal COX2 and mTOR expression in chronic gastritis: Implications for cancer progression? ( 28668512 )
2017
24
Eosinophilic gastritis with involvement of esophageal gastricA inlet patch. ( 29108982 )
2017
25
ULCERATIVE AND NECROTIZING GASTRITIS IN A CAPTIVE SLOTH (BRADYPUS VARIEGATUS, XENARTHRA, BRADYPODIDAE) DUE TO SEVERE PARASITISM WITH PARALEIURIS LOCCHII (NEMATODA, SPIROCERCIDAE). ( 28363065 )
2017
26
The challenging diagnosis of autoimmune atrophic gastritis. ( 28040990 )
2017
27
Chinese Classical Formula Sijunzi Decoction and Chronic Atrophic Gastritis: Evidence for Treatment Approach? ( 29138645 )
2017
28
Russell body gastritis with Dutcher bodies evaluated using magnification endoscopy. ( 28874963 )
2017
29
Gastritis cystica profunda mimicking a GIST - A diagnostic challenge. ( 28935123 )
2017
30
Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer. ( 28465717 )
2017
31
An Atypical Presentation of Chronic Atrophic Gastritis: Hemolytic Anemia and Mesenteric Panniculitis. ( 28758037 )
2017
32
Autoimmune atrophic gastritis: current perspectives. ( 28223833 )
2017
33
Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection. ( 28918609 )
2017
34
EVALUATION OF HUMAN LEUKOCYTE ANTIGEN CLASS I AND II ANTIGENS IN HELICOBACTER PYLORI-POSITIVE PEDIATRIC PATIENTS WITH ACTIVE GASTRITIS AND DUODENAL ULCER. ( 28977115 )
2017
35
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. ( 28487082 )
2017
36
Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis. ( 28405320 )
2017
37
Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies. ( 28816977 )
2017
38
Interleukin-17C in Human Helicobacter pylori Gastritis. ( 28739826 )
2017
39
Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis. ( 28337217 )
2017
40
Upper gastrointestinal symptoms in autoimmune gastritis: A cross-sectional study. ( 28072728 )
2017
41
Median Arcuate Ligament Syndrome: It Is Not Always Gastritis. ( 28904981 )
2017
42
Hypereosinophilic Syndrome With Eosinophilic Gastritis. ( 28491930 )
2017
43
Granulomatous gastritis induced by onychophagia: First case report. ( 29054319 )
2017
44
Collagenous Gastritis and<i>Helicobacter pylori</i>Infection: A Mere Coincidence? ( 29367938 )
2017
45
Gastric cancer associated with refractory cytomegalovirus gastritis. ( 28884453 )
2017
46
The efficacy of Jianpi Yiqi therapy for chronic atrophic gastritis: A systematic review and meta-analysis. ( 28738092 )
2017
47
Long non-coding RNA polymorphisms in 6p21.1 are associated with atrophic gastritis risk and gastric cancer prognosis. ( 29221129 )
2017
48
Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50A years: A cross-sectional study. ( 29034535 )
2017
49
Recurrent anaemia in a patient with lymphocytic gastritis and vitamin B12 deficiency. ( 28943131 )
2017
50
Unusual presentation of infection by Helicobacter pylori: gastritis associated with Russell bodies, infrequent and poorly understood pathology. ( 27990837 )
2017

Variations for Gastritis

Expression for Gastritis

Search GEO for disease gene expression data for Gastritis.

Pathways for Gastritis

Pathways related to Gastritis according to GeneCards Suite gene sharing:

(show all 19)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.81 CXCL1 CXCL8 IL1B IL1RN NOS2 PTGS2
2
Show member pathways
12.22 CHGA DEFA5 DEFB1 S100A8
3
Show member pathways
12.09 CXCL8 IL1B NOS2 PTGS2
4
Show member pathways
12.05 CXCL1 CXCL8 IL1B PTGS2 S100A8
5 11.79 CXCL1 IL1B PTGS2
6 11.78 CXCL1 CXCL8 IL1B
7 11.76 CXCL8 IL1B NOS2 PTGS2
8 11.72 CXCL8 IL1B PTGS2
9 11.69 CXCL1 CXCL8 IL1B
10 11.65 CXCL1 CXCL8 IL1B NOS2
11 11.59 CXCL8 IL1B NOS2
12 11.49 CXCL1 CXCL8 IL1B NOS2
13 11.44 CXCL1 CXCL8 IL1B
14 11.43 CXCL1 CXCL8 IL1B NOS2 PTGS2
15 11.36 CXCL8 NOS2 PTGS2
16
Show member pathways
11.26 CXCL8 IL1B NOS2 PTGS2
17
Show member pathways
11.24 PGA3 PGA4 PGA5
18 10.71 CXCL1 CXCL8 IL1B IL1RN PTGS2
19 10.16 GAST HRH2

GO Terms for Gastritis

Cellular components related to Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.77 AREG CHGA CXCL1 CXCL8 DEFA5 DEFB1
2 extracellular region GO:0005576 9.53 ADH7 CHGA CXCL1 CXCL8 DEFA5 DEFB1
3 multivesicular body lumen GO:0097486 9.33 PGA3 PGA4 PGA5

Biological processes related to Gastritis according to GeneCards Suite gene sharing:

(show all 22)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.97 CXCL1 CXCL8 DEFB1 HRH2 IL1B IL1RN
2 inflammatory response GO:0006954 9.88 CXCL1 CXCL8 IL1B IL1RN PTGS2 S100A8
3 chemotaxis GO:0006935 9.87 CXCL1 CXCL8 DEFB1 S100A8
4 defense response to bacterium GO:0042742 9.85 CHGA DEFA5 DEFB1 NOS2 S100A8
5 defense response GO:0006952 9.83 CXCL1 CXCL8 DEFA5 DEFB1
6 defense response to Gram-positive bacterium GO:0050830 9.78 CHGA DEFA5 DEFB1
7 response to lipopolysaccharide GO:0032496 9.77 CXCL1 IL1B NOS2 PTGS2 S100A8
8 neutrophil chemotaxis GO:0030593 9.76 CXCL8 IL1B S100A8
9 response to glucocorticoid GO:0051384 9.75 AREG IL1RN PTGS2
10 defense response to Gram-negative bacterium GO:0050829 9.73 CHGA DEFA5 DEFB1 NOS2
11 autophagy GO:0006914 9.72 PGA3 PGA4 PGA5 PGC S100A8
12 response to bacterium GO:0009617 9.69 ADH7 DEFB1 NOS2
13 defense response to fungus GO:0050832 9.65 CHGA DEFA5 S100A8
14 negative regulation of blood vessel diameter GO:0097756 9.6 CHGA PTGS2
15 peptidyl-cysteine S-nitrosylation GO:0018119 9.56 NOS2 S100A8
16 antimicrobial humoral response GO:0019730 9.56 CHGA DEFA5 DEFB1 S100A8
17 fever generation GO:0001660 9.55 IL1B IL1RN
18 positive regulation of fever generation GO:0031622 9.54 IL1B PTGS2
19 regulation of receptor activity GO:0010469 9.5 AREG CXCL1 CXCL8 GAST GHRL IL1B
20 protein catabolic process GO:0030163 9.46 PGA3 PGA4 PGA5 PGC
21 digestion GO:0007586 9.02 PGA3 PGA4 PGA5 PGC TFF2
22 G-protein coupled receptor signaling pathway GO:0007186 10.14 AREG CXCL1 CXCL8 DEFB1 GAST GHRL

Molecular functions related to Gastritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.35 AREG CXCL1 CXCL8 IL1B IL1RN
2 interleukin-1 receptor binding GO:0005149 9.16 IL1B IL1RN
3 aspartic-type endopeptidase activity GO:0004190 8.92 PGA3 PGA4 PGA5 PGC

Sources for Gastritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....